Conduction remodeling in human end-stage nonischemic left ventricular cardiomyopathy

Circulation

Volumn 125, Issue 15, 2012, Pages 1835-1847

  Glukhov, Alexey V ^a   Fedorov, Vadim V ^a   Kalish, Paul W ^a   Ravikumar, Vinod K ^a   Lou, Qing ^a   Janks, Deborah ^a   Schuessler, Richard B ^b   Moazami, Nader ^b   Efimov, Igor R ^a  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

cardiomyopathy; conduction velocity; congestive heart failure; optical mapping; repolarization

Indexed keywords

CONNEXIN 43; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; NERVE CELL ADHESION MOLECULE;

ANISOTROPY; ARRHYTHMOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOWN REGULATION; ELECTROPHYSIOLOGY; ENDOCARDIUM; EPICARDIUM; HEART ARRHYTHMIA; HEART CONDUCTION; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE REMODELING; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ACTION POTENTIALS; ANIMALS; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; CONNEXIN 43; DOGS; HEART FAILURE; HUMANS; PHOSPHORYLATION;

EID: 84859752570     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.047274     Document Type: Article

References (49)

1. Soltysinska E, Olesen SP, Christ T, Wettwer E, Varro A, Grunnet M, Jespersen T. Transmural expression of ion channels and transporters in human nondiseased and end-stage failing hearts. Pflugers Arch. 2009; 459:11-23.
2. Nass RD, Aiba T, Tomaselli GF, Akar FG. Mechanisms of disease: ion channel remodeling in the failing ventricle. Nat Clin Pract Cardiovasc Med. 2008;5:196-207.
3. Lou Q, Fedorov VV, Glukhov AV, Moazami N, Fast VG, Efimov IR. Transmural heterogeneity and remodeling of ventricular excitation-contraction coupling in human heart failure. Circulation. 2011;123: 1881-1890.
4. Tomaselli GF, Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res. 1999;42:270-283.
5. Akar FG, Spragg DD, Tunin RS, Kass DA, Tomaselli GF. Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circ Res. 2004;95:717-725.
6. de Bakker JM, van Capelle FJ, Janse MJ, Tasseron S, Vermeulen JT, de Jonge N, Lahpor JR. Fractionated electrograms in dilated cardiomyopathy: origin and relation to abnormal conduction. J Am Coll Cardiol. 1996;27:1071-1078.
7. Unverferth DV, Baker PB, Swift SE, Chaffee R, Fetters JK, Uretsky BF, Thompson ME, Leier CV. Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol. 1986;57:816-820.
8. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res. 2004;95:754-763.
9. Akar FG, Rosenbaum DS. Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure. Circ Res. 2003;93: 638-645.
10. Poelzing S, Rosenbaum DS. Altered connexin43 expression produces arrhythmia substrate in heart failure. Am J Physiol Heart Circ Physiol. 2004;287:H1762-H1770.
11. Glukhov AV, Fedorov VV, Lou Q, Ravikumar VK, Kalish PW, Schuessler RB, Moazami N, Efimov IR. Transmural dispersion of repo-larization in failing and nonfailing human ventricle. Circ Res. 2010;106: 981-991.
12. Taggart P, Sutton PM, Opthof T, Coronel R, Trimlett R, Pugsley W, Kallis P. Transmural repolarisation in the left ventricle in humans during normoxia and ischaemia. Cardiovasc Res. 2001;50:454-462.
13. Akar FG, Nass RD, Hahn S, Cingolani E, Shah M, Hesketh GG, DiSil-vestre D, Tunin RS, Kass DA, Tomaselli GF. Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure. Am J Physiol Heart Circ Physiol. 2007;293: H1223-H1230.
14. Anderson KP, Walker R, Urie P, Ershler PR, Lux RL, Karwandee SV. Myocardial electrical propagation in patients with idiopathic dilated car-diomyopathy. J Clin Invest. 1993;92:122-140.
15. Ueda N, Zipes DP, Wu J. Functional and transmural modulation of M cell behavior in canine ventricular wall. Am J Physiol Heart Circ Physiol. 2004;287:H2569-H2575.
16. Voss F, Opthof T, Marker J, Bauer A, Katus HA, Becker R. There is no transmural heterogeneity in an index of action potential duration in the canine left ventricle. Heart Rhythm. 2009;6:1028-1034.
17. Fedorov VV, Glukhov AV, Chang R, Kostecki G, Aferol H, Hucker WJ, Wuskell JP, Loew LM, Schuessler RB, Moazami N, Efimov IR. Optical mapping of the isolated coronary-perfused human sinus node. J Am Coll Cardiol. 2010;56:1386-1394.
18. Fedorov VV, Glukhov AV, Ambrosi CM, Kostecki G, Chang R, Janks D, Schuessler RB, Moazami N, Nichols CG, Efimov IR. Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts. J Mol Cell Cardiol. 2011;51:215-225.
19. Fedorov VV, Glukhov AV, Sudharshan S, Egorov Y, Rosenshtraukh LV, Efimov IR. Electrophysiological mechanisms of antiarrhythmic protection during hypothermia in winter hibernating versus nonhibernating mammals. Heart Rhythm. 2008;5:1587-1596.
20. Fedorov VV, Schuessler RB, Hemphill M, Ambrosi CM, Chang R, Voloshina AS, Brown K, Hucker WJ, Efimov IR. Structural and functional evidence for discrete exit pathways that connect the canine sino-atrial node and atria. Circ Res. 2009;104:915-923.
21. Ai X, Pogwizd SM. Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A. Circ Res. 2005;96:54-63.
22. Antzelevitch C, Sicouri S, Litovsky SH, Lukas A, Krishnan SC, Di Diego JM, Gintant GA, Liu DW. Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. Circ Res. 1991;69:1427-1449.
23. Bruce AF, Rothery S, Dupont E, Severs NJ. Gap junction remodelling in human heart failure is associated with increased interaction of connexin43 with ZO-1. Cardiovasc Res. 2008;77:757-765.
24. Kostin S, Rieger M, Dammer S, Hein S, Richter M, Klovekorn WP, Bauer EP, Schaper J. Gap junction remodeling and altered connexin43 expression in the failing human heart. Mol Cell Biochem. 2003;242: 135-144.
25. Smyth JW, Hong TT, Gao D, Vogan JM, Jensen BC, Fong TS, Simpson PC, Stainier DY, Chi NC, Shaw RM. Limited forward trafficking of connexin 43 reduces cell-cell coupling in stressed human and mouse myocardium. J Clin Invest. 2010;120:266-279.
26. Musil LS, Goodenough DA. Biochemical analysis of connexin43 intra-cellular transport, phosphorylation, and assembly into gap junctional plaques. J Cell Biol. 1991;115:1357-1374.
27. Antzelevitch C. Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am J Physiol Heart Circ Physiol. 2007;293:H2024-H2038.
28. Brugada J, Boersma L, Kirchhof CJ, Heynen VV, Allessie MA. Reentrant excitation around a fixed obstacle in uniform anisotropic ventricular myocardium. Circulation. 1991;84:1296-1306.
29. Hombach V. Electrocardiogram of the failing heart. Card Electrophysiol Rev. 2002;6:209-214.
30. Mancini DM, Wong KL, Simson MB. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation. 1993;87:1083-1092.
31. Brugada J, Mont L, Boersma L, Kirchhof C, Allessie MA. Differential effects of heptanol, potassium, and tetrodotoxin on reentrant ventricular tachycardia around a fixed obstacle in anisotropic myocardium. Circulation. 1991;84: 1307-1318.
32. Delgado C, Steinhaus B, Delmar M, Chialvo DR, Jalife J. Directional differences in excitability and margin of safety for propagation in sheep ventricular epicardial muscle. Circ Res. 1990;67:97-110.
33. Delmar M, Michaels DC, Johnson T, Jalife J. Effects of increasing intercellular resistance on transverse and longitudinal propagation in sheep epicardial muscle. Circ Res. 1987;60:780-785.
34. Efimov IR, Ermentrout B, Huang DT, Salama G. Activation and repo-larization patterns are governed by different structural characteristics of ventricular myocardium: experimental study with voltage-sensitive dyes and numerical simulations. J Cardiovasc Electrophysiol. 1996;7: 512-530.
35. Conrath CE, Wilders R, Coronel R, de Bakker JM, Taggart P, de Groot JR, Opthof T. Intercellular coupling through gap junctions masks M cells in the human heart. Cardiovasc Res. 2004;62:407-414.
36. Efimov IR, Huang DT, Rendt JM, Salama G. Optical mapping of repo-larization and refractoriness from intact hearts. Circulation. 1994;90: 1469-1480.
37. Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, Marban E, Tomaselli GF. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res. 1996;78:262-273.
38. Valdivia CR, Chu WW, Pu J, Foell JD, Haworth RA, Wolff MR, Kamp TJ, Makielski JC. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol. 2005;38:475-483.
39. Kaab S, Dixon J, Duc J, Ashen D, Nabauer M, Beuckelmann DJ, Steinbeck G, McKinnon D, Tomaselli GF. Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation. 1998;98:1383-1393.
40. Dupont E, Matsushita T, Kaba RA, Vozzi C, Coppen SR, Khan N, Kaprielian R, Yacoub MH, Severs NJ. Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol. 2001;33:359-371.
41. Shaw RM, Fay AJ, Puthenveedu MA, von Zastrow M, Jan YN, Jan LY. Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions. Cell. 2007;128:547-560.
42. Li J, Patel VV, Kostetskii I, Xiong Y, Chu AF, Jacobson JT, Yu C, Morley GE, Molkentin JD, Radice GL. Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesis. Circ Res. 2005;97:474-481.
43. Wei CJ, Francis R, Xu X, Lo CW. Connexin43 associated with an N-cadherin-containing multiprotein complex is required for gap junction formation in NIH3T3 cells. J Biol Chem. 2005;280:19925-19936.
44. Lampe PD, Lau AF. The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol. 2004;36:1171-1186.
45. van Veen TA, van Rijen HV, Jongsma HJ. Physiology of cardiovascular gap junctions. Adv Cardiol. 2006;42:18-40.
46. Kitamura H, Ohnishi Y, Yoshida A, Okajima K, Azumi H, Ishida A, Galeano EJ, Kubo S, Hayashi Y, Itoh H, Yokoyama M. Heterogeneous loss of connexin43 protein in nonischemic dilated cardiomyopathy with ventricular tachycardia. J Cardiovasc Electrophysiol. 2002;13:865-870.
47. Wiegerinck RF, de Bakker JM, Opthof T, de Jonge N, Kirkels H, Wilms-Schopman FJ, Coronel R. The effect of enhanced gap junctional conductance on ventricular conduction in explanted hearts from patients with heart failure. Basic Res Cardiol. 2009;104:321-332.
48. Muller A, Schaefer T, Linke W, Tudyka T, Gottwald M, Klaus W, Dhein S. Actions of the antiarrhythmic peptide AAP10 on intercellular coupling. Naunyn Schmiedebergs Arch Pharmacol. 1997;356:76-82.
49. Dhein S, Larsen BD, Petersen JS, Mohr FW. Effects of the new antiar-rhythmic peptide ZP123 on epicardial activation and repolarization pattern. Cell Commun Adhes. 2003;10:371-378.